Glucose-enriched dialysate and tolerance to maintenance hemodialysis.
10 patients entered a controlled 4-week study to evaluate the effect of a glucose-enriched dialysate (400 mg/100 ml) on hemodialysis tolerance. Headache during and after dialysis and post-dialysis fatigue decreased in a statistically significant manner. The average glycemia was only moderately increased with an adequate insulin response. Blood cholesterol and triglycerides did not vary signifcantly during this short study period.
D000328:Adult; D000368:Aged; D005221:Fatigue / Q000517:prevention & control; D005260:Female; D005921:Glomerulonephritis / Q000628:therapy; D005947:Glucose / Q000008:administration & dosage*; D006261:Headache / Q000517:prevention & control; D006801:Humans; D007022:Hypotension / Q000517:prevention & control; D007674:Kidney Diseases / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009400:Nephrosclerosis / Q000628:therapy; D007690:Polycystic Kidney Diseases / Q000628:therapy; D011704:Pyelonephritis / Q000628:therapy; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*
D005947:Glucose